Ignite Creation Date:
2024-05-06 @ 4:04 AM
Last Modification Date:
2024-10-26 @ 11:43 AM
Study NCT ID:
NCT02449551
Status:
COMPLETED
Last Update Posted:
2022-06-15
First Post:
2015-05-14
Brief Title:
Study of AZD6094 Volitinib in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Gastric Adenocarcinoma |
Keywords: